These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6419591)

  • 21. Gold in rheumatoid arthritis; the past, present and future. Proceedings of a symposium held in Copenhagen, April 15-16, 1983.
    Scand J Rheumatol Suppl; 1983; 51():1-139. PubMed ID: 6426042
    [No Abstract]   [Full Text] [Related]  

  • 22. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
    Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Auranofin (Ridaura). A peroral gold salt].
    Manthorpe R
    Ugeskr Laeger; 1985 Mar; 147(10):888-90. PubMed ID: 3920800
    [No Abstract]   [Full Text] [Related]  

  • 24. Auranofin in the treatment of rheumatoid arthritis. A two-year study.
    Baldassare AR; Weiss TD; Arthur RE; Osborn TG; Moore TL; Zuckner J
    Mo Med; 1985 Nov; 82(11):711-5. PubMed ID: 3934512
    [No Abstract]   [Full Text] [Related]  

  • 25. [Evaluation of lymphocyte subpopulations using monoclonal antibodies in patients with rheumatoid arthritis undergoing treatment with a new gold salt (auranofin)].
    Di Matteo L; D'Incecco V; Evangelista L; Castiglione C; Consoli G
    Boll Soc Ital Biol Sper; 1985 May; 61(5):777-81. PubMed ID: 3927943
    [No Abstract]   [Full Text] [Related]  

  • 26. [Preliminary results of oral gold treatment with auranofin following lack of success of intramuscular gold therapy].
    Rainer F; Ulreich A
    Wien Klin Wochenschr Suppl; 1984; 156():49-51. PubMed ID: 6442058
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of auranofin dose regimen change upon cell-associated gold in rheumatoid arthritic patients.
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol; 1981; 8(5):829-32. PubMed ID: 6796684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of auranofin and sodium aurothiomalate on peripheral blood monocytes.
    Scheinberg MA; Santos LM; Finkelstein AE
    J Rheumatol; 1982; 9(3):366-9. PubMed ID: 6288942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of in vitro and in vivo effects of gold compounds on leukocyte function: possible mechanisms of action.
    Wolach B; DeBoard JE; Coates TD; Baehner RL; Boxer LA
    J Lab Clin Med; 1982 Jul; 100(1):37-44. PubMed ID: 6283001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of action of auranofin: effects on humoral immune response.
    Walz DT; Dimartino MJ; Griswold DE
    J Rheumatol Suppl; 1982; 8():32-6. PubMed ID: 6813489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The role of chrysothiotherapy in the treatment of progressive polyarthritis].
    Vojtísek O; Dostál C; Pavelka K
    Fysiatr Revmatol Vestn; 1984 Apr; 62(2):106-12. PubMed ID: 6430770
    [No Abstract]   [Full Text] [Related]  

  • 32. Cell-bound gold (CBG) in patients treated with aurothioglucose and with auranofin. A comparison of different methods of determination.
    van Riel PL; Gribnau FW; van de Putte LB
    J Rheumatol; 1983 Aug; 10(4):574-8. PubMed ID: 6413685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral gold therapy in rheumatoid arthritis: auranofin.
    Am J Med; 1983 Dec; 75(6A):1-164. PubMed ID: 6419590
    [No Abstract]   [Full Text] [Related]  

  • 34. Modulation of neutrophil functions by auranofin. Studies on effects in vitro and in rheumatoid arthritis patients.
    Hafström I; Udén AM; Palmblad J
    Scand J Rheumatol; 1983; 12(2):97-105. PubMed ID: 6407101
    [No Abstract]   [Full Text] [Related]  

  • 35. Induction of mammalian stress proteins by a triethylphosphine gold compound used in the therapy of rheumatoid arthritis.
    Caltabiano MM; Koestler TP; Poste G; Greig RG
    Biochem Biophys Res Commun; 1986 Aug; 138(3):1074-80. PubMed ID: 3092816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gold levels produced by treatment with auranofin and sodium aurothiomalate.
    Lewis D; Capell HA; McNeil CJ; Iqbal MS; Brown DH; Smith WE
    Ann Rheum Dis; 1983 Oct; 42(5):566-70. PubMed ID: 6414387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of auranofin on the colonic transport of Na+ and fluid in the rat.
    Hardcastle J; Hardcastle PT; Kelleher DK; Fondacaro JD
    J Pharm Pharmacol; 1986 Jun; 38(6):466-8. PubMed ID: 2873225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Long-term tolerance of oral gold therapy in rheumatoid arthritis. Frequency and intensity of undesirable side effects].
    Goebel KM; Storck U
    Schweiz Med Wochenschr; 1985 Dec; 115(49):1775-7. PubMed ID: 3937234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gold nephropathy due to auranofin obscured by tolmetin pseudoproteinuria.
    Wilson AP; Prouse PJ; Gumpel JM
    Ann Rheum Dis; 1984 Jun; 43(3):511-2. PubMed ID: 6430252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of a new antirheumatic drug, triethylphosphine gold (auranofin), on in vitro lymphocyte and monocyte cytotoxicity.
    Russell AS; Davis P; Miller C
    J Rheumatol; 1982; 9(1):30-5. PubMed ID: 6806471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.